Use of Real‐World Data and Evidence in Drug Development of Medicinal Products Centrally Authorized in Europe in 2018–2019

Real‐world data/real‐world evidence (RWD/RWE) are considered to have a great potential to complement, in some cases, replace the evidence generated through randomized controlled trials. By tradition, use of RWD/RWE in the postauthorization phase is well‐known, whereas published evidence of use in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Eskola, Sini Marika, Leufkens, Hubertus Gerardus Maria, Bate, Andrew, De Bruin, Marie Louise, Gardarsdottir, Helga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299055/
https://www.ncbi.nlm.nih.gov/pubmed/34689334
http://dx.doi.org/10.1002/cpt.2462

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299055/
https://www.ncbi.nlm.nih.gov/pubmed/34689334
http://dx.doi.org/10.1002/cpt.2462

Ejemplares similares